1Life Healthcare Inc. (ONEM)
NASDAQ: ONEM
· Real-Time Price · USD
16.47
0.00 (0.00%)
At close: Feb 21, 2023, 10:00 PM
1Life Healthcare Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Net Fee-For-Service Revenue Revenue | 157.24M | 181.81M | 68.47M | 52.13M |
| Net Fee-For-Service Revenue Revenue Growth | -13.52% | +165.55% | +31.32% | n/a |
| Capitated Medicare Revenue Revenue | 517.39M | 126.61M | 159.48M | 78.73M |
| Capitated Medicare Revenue Revenue Growth | +308.66% | -20.61% | +102.56% | n/a |
| Commercial Revenue Revenue | 516.64M | 493.34M | n/a | n/a |
| Commercial Revenue Revenue Growth | +4.72% | n/a | n/a | n/a |
| Fee-For-Service And Other Medicare Revenue Revenue | 11.51M | 3.37M | n/a | n/a |
| Fee-For-Service And Other Medicare Revenue Revenue Growth | +241.66% | n/a | n/a | n/a |
| Medicare Revenue Revenue | 528.91M | 129.98M | n/a | n/a |
| Medicare Revenue Revenue Growth | +306.92% | n/a | n/a | n/a |
| Membership Revenue Revenue | 102.09M | 85.71M | n/a | n/a |
| Membership Revenue Revenue Growth | +19.11% | n/a | n/a | n/a |
| Partnership Revenue Revenue | 257.31M | 224.05M | n/a | n/a |
| Partnership Revenue Revenue Growth | +14.84% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 135.33M | 142.46M | 115.61M | 119.5M | 112.87M | 107.45M | 87.77M | 77.03M | 47.17M | 47.97M | 48.09M | 51.02M | 42.49M | 40.24M | 35.06M | 30.69M | 39.63M |
| Selling, General, and Administrative Revenue Growth | -5.01% | +23.22% | -3.25% | +5.87% | +5.05% | +22.43% | +13.93% | +63.32% | -1.68% | -0.24% | -5.75% | +20.08% | +5.58% | +14.78% | +14.23% | -22.54% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 25.03M | 26.38M | 23.19M | 22.46M | 24.36M | 14.38M | 10.57M | 12.69M | 8.12M | 7.91M | 9.78M | 11.15M | 10.69M | 12.46M | 8.09M | 8.28M | 11.41M |
| Sales and Marketing Revenue Growth | -5.12% | +13.75% | +3.27% | -7.78% | +69.37% | +36.05% | -16.70% | +56.25% | +2.62% | -19.05% | -12.35% | +4.35% | -14.23% | +54.05% | -2.22% | -27.51% | n/a |